Evolutionary Genomics, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year Three
Evolutionary Genomics, Inc. had Finite-Lived Intangible Asset, Expected Amortization, Year Three of $2.60 thousand as of 2022-12-31, per its 10-K filed 2023-03-09.
Discontinued › Notes › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree · last filed 2023-03-09
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Three $2.60K.
- 2022-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year Three $638.11K.
- 2022-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year Three $638.11K.
- 2022-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year Three $638.11K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Three |
|---|---|
| 2022-12-31 | $2.60K 10-K · filed 2023-03-09 |
| 2022-09-30 | $638.11K 10-Q · filed 2022-10-21 |
| 2022-06-30 | $638.11K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $638.11K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $638.11K 10-K · filed 2022-03-22 |
| 2021-09-30 | $1.01M 10-Q · filed 2021-11-01 |
| 2021-06-30 | $1.01M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $1.01M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $1.01M 10-K · filed 2021-03-31 |
| 2020-09-30 | $317.63K 10-Q · filed 2020-11-13 |